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Lung cancer screening programmes using chest X-ray and sputum cytology are routinely performed in Japan; however, the efficacy is
insufficient. Screening using low-dose computed tomography (CT) is a more effective approach and has the potential to detect the
disease more accurately. A total of 7183 low-dose CT screening tests for 4689 participants and 36085 chest X-ray screening tests for
13381 participants were conducted between August 1998 and May 2002. Sensitivity and specificity of lung cancer screening were
calculated by both the detection method and the incidence method by linkage of the screening database and the Cancer Registry
database. The preclinical detectable phase was assumed to be 1 year. Sensitivity and specificity by the detection method were 88.9
and 92.6% for low-dose CT and 78.3 and 97.0% for chest X-ray, respectively. Sensitivity of low-dose CT by the incidence method
was 79.5%, whereas that of chest X-ray was 86.5%. Lung cancer screening using low-dose CT resulted in higher sensitivity and lower
specificity than traditional screening according to the detection method. However, sensitivity by the incidence method was not as
high as this. These findings demonstrate the potential for overdiagnosis in CT screening-detected cases.
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Lung cancer is the leading cause of cancer death in Japan, with
45927 men and 17307 women dying from lung cancer in 2006.
Since 1987, lung cancer screening programme using chest X-ray
and sputum cytology for all residents aged 40 years of age and
older regardless of smoking status has been conducted by the
Ministry of Health and Welfare. Unfortunately, the efficacy of lung
cancer screening using chest X-ray and sputum cytology is
insufficient (Fontana et al, 1986; Marcus et al, 2000a, 2006b;
Sagawa et al, 2003a). Therefore, a more effective approach is
required to decrease lung cancer deaths.
Annual lung cancer screening using low-dose computed
tomography (CT) has been performed as an opportunistic
screening method since the early 1990s in Japan. Several study
groups introduced low-dose CT for population-based screening in
clinical trials. These previous studies reported a high detection
rate, an ability to detect small tumours and a high survival rate in
detected cases (Henschke et al, 2001, 2006; Sone et al, 2001; Nawa
et al, 2002; Sobue et al, 2002a; Swensen et al, 2002; Diederich et al,
2004; Jett, 2005; Libby et al, 2006). Some studies referred to interval
cancer cases of lung cancer screening using low-dose CT, and one
study referred to the sensitivity of screening (Sone et al, 2001;
Diederich et al, 2004). However, screening databases are yet to be
linked to a cancer registry, which is essential for accurate
evaluation of screening, including the confirmation of all interval
cancer cases. To date, no study has been conducted on sensitivity
and specificity of annual lung cancer screening using low-dose CT
and cancer registry data. Therefore, the present study was
conducted to evaluate sensitivity and specificity of annual lung
cancer screening using low-dose CT and data from screening and
local cancer registry databases.
MATERIALS AND METHODS
Study setting
Since 1998, annual population-based lung cancer screening using
low-dose CT has been conducted at five municipalities in Osaka
prefecture: A (city), B (city), C (town), D (town) and E (town). All
residents aged 40 years of age and older were recruited by mail
using a letter from the public health division of each municipality
regardless of smoking status. Subjects recruited to the lung cancer
screening programme underwent either miniature chest X-ray or
low-dose chest CT.
As a principle, heavy smokers were recommended to undergo
low-dose CT screening. In addition, the persons who want to
undergo low-dose CT screening also underwent low-dose CT
screening. Others underwent chest X-ray screening.
A high-risk group for lung cancer, smokers with over a 20 pack
index or who had haemosputum, was examined by 3-day pooled
sputum cytology.
Low-dose CT or chest X-ray images were reviewed and classified
by two trained physicians to determine the need for further clinical
examination. Sputum cytology was also performed by a certified
cytopathologist to determine the need for further clinical
examination.
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sThose diagnosed with the need for further clinical examination
were regarded as screen-positive. These individuals were asked to
undergo further diagnostic evaluation at Osaka Medical Center for
Cancer and Cardiovascular Disease. All individuals with positive
chest X-ray screening were asked to undergo chest CT as a further
examination.
Data collection
All subjects were individuals who had undergone either low-dose
CT or chest X-ray screening tests between August 1998 and May
2002. The following participants were excluded from the analyses:
(1) participants who had a past history of lung cancer, (2)
participants who were suspected of having lung cancer by a
previous screening or other medical examination and had received
medical treatment and (3) participants who were suspected of
having lung cancer at the previous screening or by other medical
examination, but had refused further examinations.
Participants were divided into two groups: (a) low-dose CT
group and (b) chest X-ray group. The low-dose CT group consisted
of persons who had undergone low-dose CT at least one time
during the study period, whereas the chest X-ray group consisted
of persons who had undergone only chest X-ray. The low-dose CT
group included those who had undergone both CT screening and
chest X-ray screening within the study period. For these cases,
screenings using chest X-ray were ignored to evaluate low-dose CT
screening.
All data were entered into the screening database that was linked
to the Osaka Cancer Registry (OCR) database with data reflecting
incidence cases through December 2003. The indices used to
collate the two databases were name, sex, address and date of birth.
Information about lung cancer cases was extracted from hospital
medical records or the OCR file.
We assumed that the preclinical detectable phase was 1 year for
interval cancer cases. For death certificate-only cases, the date of 3
months before death was regarded as the date of diagnosis. Using
these parameters, all lung cancer cases diagnosed within 1 year
after a negative screen were regarded as interval lung cancers.
Screen-detected cases were considered as true-positive cases
regardless of the time between the date of screening and the date
of diagnosis.
Statistical analyses
The sensitivity of screening was calculated by both the detection
method and the incidence method. Although the detection method
is simple and widely used, sensitivity estimated by detection
method is affected by length and overdiagnosis biases (Day, 1985).
The incidence method is not affected by length or overdiagnosis
bias and is often used for breast cancer screening or colorectal
cancer screening (Fletcher et al, 1993; Zappa et al, 2001).
Detection method
Sensitivity and specificity were calculated by the detection method
using the following formulae.
Truediseasestate
Screeningtest
þ 
þ ab
  cd
Sensitivity ¼ a=ða þ cÞ
Specificity ¼ d=ðb þ dÞ
Sensitivity and specificity calculated by the detection method were
stratified by smoking status, histological type and screening rank.
The screening rank was classified as the initial and repeated
screenings, regardless of the number of years since the initial
screening.
Incidence method
In addition, we calculated sensitivity by the incidence method
using the following approximate formula (Day, 1985; Zappa et al,
2001):
Sensitivity ¼ 1  ½ IðtÞ=I 
Where I(t)¼the observed number of interval cancer cases during
time t and I¼the expected number of cases in the absence of
screening.
We calculated the number of expected lung cancer cases in the
absence of screening based on the following data. Age-specific lung
cancer incidence rates provided from the OCR in 2001 were 16.3,
61.6, 180.9, 477.3 and 770.2 (per 100000 person-years) for men,
and 6.3, 25.9, 53.4, 116.7 and 241.3 for women, for age groups
40–49, 50–59, 60–69, 70–79 and X80, respectively. Lung cancer
incidence rates in the OCR were weighted by smoking status.
According to the previous large-scale cohort study in Japan, the
lung cancer incidence rates among ex-smokers and current
smokers were assumed to be 2.2 times and 4.5 times of that of
nonsmokers, respectively, among men, and 3.7 times and 4.2
times, respectively, among women (Sobue et al, 2002b). According
to an official report from Osaka prefecture in 2003, the proportions
of current smokers, ex-smokers and nonsmokers were 40, 30 and
30% among men, and 11, 7 and 82% among women, respectively
(Department of public health, Osaka Prefecuture, 2006).
We assumed that smoking status proportions were the same
across all age groups, so the expected incidence rate according to
sex and smoking status was modified using the following formulae:
Expectedincidencerateamongmalenonsmokers
¼ IncidencerateinOCR=ð4:5 0:40 þ 2:2 0:30 þ 1 0:30Þ
Expectedincidencerateamongfemalenonsmokers
¼ IncidencerateinOCR=ð4:2 0:11 þ 3:7 0:07 þ 1 0:82Þ
The expected incidence rates for ex-smokers and current smokers
were assumed to be 2.2 times and 4.5 times of that of nonsmokers,
respectively, among men, and 3.7 times and 4.2 times, respectively,
among women.
The differences in sensitivity and specificity among the stratified
variables were tested by w
2 test. All statistical analyses were
performed using SAS software, version 8.01 (SAS Institute Inc.,
Cary, NC, USA).
Ethical approval
The protocol for the present study was approved by the Ethics
Committee of Osaka Medical Center for Cancer and Cardio-
vascular Disease, Osaka, Japan. Informed consent for participation
in the clinical trial, including CT screening, was obtained from all
individuals.
RESULTS
From August 1998 to May 2002, a total of 7190 low-dose CT
screening tests and a total of 36085 chest X-ray screening tests
were performed. Seven screening participants were excluded from
analysis because they did not meet the eligibility criteria.
Participants were ineligible for the following reasons: two
participants were under follow-up care, one was suspected of
having lung cancer but refused further examination and four had a
history of lung cancer. A total of 7183 low-dose CT screening tests
for 4689 participants (2765 men and 1924 women) and 36085 chest
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sX-ray screening tests for 13381 participants (4180 men and 9201
women) enrolled in the study.
Table 1 shows the number of screening tests by sex, age group,
smoking status and rank of screening tests. Most of the
participants who underwent low-dose CT screening were male
current smokers or ex-smokers. Sputum cytology was additionally
performed for 3539 screening tests for the low-dose CT group and
5417 screening tests for the chest X-ray group.
Forty cases in the low-dose CT group and 29 cases in the chest
X-ray group were detected by the screening. Five interval cases in
the low-dose CT group and eight interval cases in the chest X-ray
group were confirmed by linkage to OCR (Table 2). All of the
interval cancer cases for both the low-dose CT group and the chest
X-ray group were smokers. As for the low-dose CT group, all of
them were nonadenocarcinoma. Two cases, one in the low-dose CT
group and one in the chest X-ray group, were detected by sputum
cytology on negative radiological screen.
Table 3 shows sensitivity and specificity by the detection method
according to histological type, smoking status and rank of
screening. As a result, sensitivity and specificity (95% confidence
interval) of screening were 88.9% (79.7–98.1%) and 92.6%
(92.0–93.2%) for the low-dose CT group, and 78.3% (65.1–91.6%)
and 97.0% (96.9–97.2%) for the chest X-ray group, respectively.
Specificity of chest X-ray screening was significantly higher than
that of low-dose CT screening (Po0.001). The difference in
sensitivity by the detection method was not significant.
As for histological type, sensitivity for adenocarcinoma was
significantly higher than that for nonadenocarcinoma (low-dose
CT: 100 vs 61.5%; Po0.001, and chest X-ray: 95.8 and 50.0%;
Po0.001); however, the histological type of three interval cases in
the chest X-ray group was unknown. As for screening rank,
specificity for the repeated screenings was significantly higher than
that for the initial screenings (low-dose CT: 95.7 vs 91.0%;
Po0.001, and chest X-ray: 97.7 vs 95.9%; Po0.001). As for sex,
specificity for men was significantly lower than that for women
(low-dose CT: 92.1 vs 93.5%; Po0.05, and chest X-ray: 95.7
vs 97.6%; Po0.001). Sensitivity of chest X-ray screening for
women was significantly higher than that for men (100 vs 68.2%;
Po0.05). As for smoking status, sensitivity of both low-dose CT
and chest X-ray for nonsmokers was 100%.
Table 4 shows sensitivity estimated by the incidence method.
Until the end of December 2003, a total of 14434 person-years
(total for men: 9173 person-years; total for women: 5512 person-
years) for the low-dose CT group and a total of 59725 person-years
(total for men: 17962 person-years; total for women: 41763
person-years) for the chest X-ray group had been followed up for.
The mean follow-up terms were 3.1 person-years and 4.5 person-
years, respectively. The number of expected lung cancer cases
was calculated to be 24.4 persons for the low-dose CT group and
59.3 persons for the chest X-ray group. As a result, sensitivity
Table 1 Number of screening tests performed by age group, smoking
status and rank; (a) low-dose CT group and (b) chest X-ray group: Osaka,
1998–2002
Male Female Total
(a) Low-dose CT group
Age (years)
40–49 700 490 1190
50–59 1147 1132 2279
60–69 1885 886 2771
70–79 690 194 884
80– 43 16 59
Smoking status
Nonsmoker 362 2048 2410
Ex-smoker 1012 113 1125
Current smoker 3091 557 3648
Rank
Initial 2765 1924 4689
Repeated 1700 794 2494
Total 4465 2718 7183
(b) Chest X-ray group
Age (years)
40–49 1258 4862 6120
50–59 1679 8632 10311
60–69 4163 7910 12073
70–79 2695 3670 6365
80– 573 643 1216
Smoking status
Nonsmoker 2807 23790 26597
Ex-smoker 4328 740 5068
Current smoker 3233 1187 4420
Rank
Initial 4180 9201 13381
Repeated 6188 16516 22704
Total 10368 25717 36085
CT¼computed tomography.
Table 2 Interval cancer cases of screening; (a) low-dose CT group and (b) chest X-ray group
Sex Age (years) Pack index Smoking status Histological type Location Rank Clinical stage
(a) Low-dose CT group
1 F 71 48 Current Squamous Unknown Initial III
2 M 60 43 Current Large cell Peripheral Initial III
3 M 72 48 Current Small cell Unknown Repeated IV
4 M 72 45 Current Squamous Unknown Repeated I
5
a F 59 29 Ex Squamous Central Initial I
(b) Chest X-ray group
1 M 68 48 Current Squamous Unknown Repeated III
2 M 83 61 Current Small cell Unknown Repeated Unknown
3 M 72 21 Ex Adeno Unknown Repeated I
4 M 69 25 Current Undifferentiated Unknown Initial III
5 M 60 50 Current Unknown Unknown Initial Unknown
6
a M 63 68 Ex Squamous Central Repeated I
7 M 59 80 Current Unknown Unknown Repeated Unknown
8 M 85 15 Ex Unknown Unknown Repeated Unknown
CT¼computed tomography.
aDetected by sputum cytology.
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79.5% (63.5–95.5%) and 86.5% (77.8–95.2%), respectively. The
difference in sensitivity by the incidence method was not
statistically significant.
Discussion
The present study is the first report on sensitivity and specificity of
annual lung cancer screening using low-dose CT and data from a
local Cancer Registry. Sensitivity and specificity of low-dose CT
screening according to the detection method were 88.9 and 92.6%.
The sensitivity estimated by the incidence method resulted in a
value of 79.5%. On the other hand, sensitivity and specificity of
chest X-ray in the same time frame by the detection method were
78.3 and 97.0%, respectively. Furthermore, sensitivity of chest
X-ray screening by the incidence method was 86.5%.
In previous studies conducted in the1980s, sensitivity and
specificity of annual lung cancer screening using chest X-ray
and sputum cytology were also evaluated by the detection method.
In those studies, sensitivity and specificity for usual screening were
63.6–88.0% and 94.7–99.6%, respectively (Sobue et al, 1991c; Soda
et al, 1993; Sagawa et al, 1994b; Tsukada et al, 2002). The use of
low-dose CT screening resulted in a higher sensitivity and lower
specificity than usual screening. The reported high sensitivity in
participants undergoing low-dose CT screening is the result of
improvement in the detection of small tumours. The lower
specificity value indicates the difficulty of diagnosing nodules
detected by screening.
Several points must be considered when the present study
results are compared with previous results. Since 1980s, lung
cancer incidence by histological type has undergone a change over
time. With a large decline in the smoking rate among men, the
proportion of squamous cell carcinoma or small cell carcinoma
has decreased, whereas the proportion of adenocarcinoma has
increased (Yoshimi et al, 2003). The current environment may be
more advantageous for lung cancer screening because adenocarci-
noma occurring in the peripheral lung has a longer doubling time
than squamous cell carcinoma (Arai et al, 1994). In addition, as
most low-dose CT screening-detected lung cancer lesions are too
small to detect by chest X-ray and have a longer preclinical phase,
simple comparison of low-dose CT screening with chest X-ray
screening is difficult.
We used the detection method and stratified analyses by
screening rank and histological type. As for screening rank,
specificity of both low-dose CT and chest X-ray for the repeated
Table 3 Sensitivity and specificity by the detection method according to histological type, smoking status and rank of screening; (a) low-dose CT group
and (b) chest X-ray group
No. of screenings Screen-detected cases Interval cases Sensitivity (%) (95% CI) Specificity (%) (95% CI)
(a) Low-dose CT group
Sex
Men 4465 29 3 90.6 (80.5–100) 92.1 (91.3–92.9)
Women 2718 11 2 84.6 (65.0–100) 93.5 (92.6–94.4)
Smoking status
Nonsmoker 2410 13 0 100 93.5 (92.5–94.4)
Ex-smoker 1125 6 1 85.7 (59.8–100) 91.5 (89.9–93.1)
Current smoker 3648 21 4 84.0 (69.6–98.4) 92.4 (91.6–93.3)
Histological type
Adenocarcinoma — 32 0 100 —
Nonadenocarcinoma — 8 5 61.5 (35.1–88.0) —
Rank
Initial 4688 32 3 91.4 (82.2–100) 91.0 (90.2–91.8)
Repeated 2494 8 2 80.0 (55.2–100) 95.7 (94.9–96.5)
Total 7183 40 5 88.9 (79.7–98.1) 92.6 (92.0–93.2)
(b) Chest X-ray group
Sex
Men 10368 15 8 65.2 (45.8–84.7) 95.7 (95.3–96.1)
Women 25717 14 0 100 97.6 (97.3–97.8)
Smoking status
Nonsmoker 26597 13 0 100 97.4 (97.3–97.7)
Ex-smoker 5068 4 3 57.1 (20.5–93.8) 95.9 (95.3–96.4)
Current smoker 4420 12 5 70.6 (48.9–92.2) 95.7 (95.1–96.3)
Histological type
Adenocarcinoma — 23 1 95.8 (87.8–100) —
Nonadenocarcinoma — 6 4 50.0 (21.7–78.3) —
Unknown — 0 3 — —
Rank
Initial 13381 13 2 86.7 (69.5–100) 95.9 (95.5–96.2)
Repeated 22704 16 6 76.2 (58.0–94.4) 97.7 (97.5–97.9)
Total 36085 29 8 78.3 (65.1–91.6) 97.0 (96.9–97.2)
CI¼confidence interval; CT¼computed tomography.
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sscreenings was significantly higher than that of the initial
screenings. The high specificity associated with repeated screen-
ings is due to the fact that the review of previous images facilitates
ruling out benign nodules. Sensitivity of low-dose CT and chest
X-ray for the repeated screenings was lower than that of the initial
screenings; however, the difference was not statistically significant.
Sensitivity for the initial screenings was affected by length bias and
overestimation because lung cancers with long preclinical detect-
able phases were more prevalent. Regarding histological type,
adenocarcinoma sensitivity estimated by the detection method was
significantly higher than that for nonadenocarcinoma for both
low-dose CT and chest X-ray. In the previous study, sensitivity of
chest X-ray was 86.4% for adenocarcinoma and 44.2% for
nonadenocarcinoma (Sobue et al, 1991c). Both low-dose CT
screening and chest X-ray screening have a high sensitivity for
the detection of adenocarcinoma. In contrast, sensitivity estimated
by the detection method for nonadenocarcinoma remained low. As
for smoking status, both low-dose CT and chest X-ray had superior
performance for nonsmokers.
Although the detection method is simple and widely used, it is
affected by overdiagnosis or length bias because cancers with long
preclinical detectable phases are included in the denominator. In
the 1980s, lung cancer was considered to be an aggressive and
rapid-growing cancer; however, it has been reported that low-dose
CT screening-detected lung cancer has a long doubling time and
good prognosis (Sone et al, 2001; Nawa et al, 2002; Sobue et al,
2002a; Swensen et al, 2002; Henschke et al, 2006; Libby et al, 2006).
The incidence method, which is not affected by overdiagnosis bias
and length bias, is preferred for the correct evaluation of low-dose
CT screening. Screening for breast cancers or colorectal cancers,
with long doubling times, has been evaluated using the incidence
method whereas lung cancer screening has been evaluated using
the detection method only (Fletcher et al, 1993; Zappa et al, 2001).
In this study, we calculated expected lung cancer incidence to be
24.4 persons for the low-dose CT group and 59.3 persons for the
chest X-ray group according to age-specific lung cancer incidence
rate in the OCR, smoking status in Osaka prefecture and the
relative risk of lung cancer incidence associated with smoking
according to a large-scale cohort study in Japan. Unexpectedly, the
sensitivity of low-dose CT screening estimated by the incidence
method (79.5%) was lower than that of chest X-ray screening
(86.5%); however, the difference was not statistically significant.
There are several possible explanations for this contradiction.
First, the mean follow-up term of the low-dose CT group
(3.1 person-years) was shorter than that of the chest X-ray group
(4.5 person-years). Furthermore, the mean pack index of current
smokers among the low-dose CT group (42 for men and 23 for
women) was somewhat higher than that of the chest X-ray group
(38 for men and 16 for women). Therefore, expected lung cancer
incidence for the low-dose CT group might be underestimated.
Second, four screen-detected cases among the chest X-ray group
were checked with lesions other than cancer. These lung cancer
cases were incidentally detected by the subsequent chest CT as a
further examination on positive tests; all of them were adeno-
carcinoma. When these cases were regarded as interval cases,
sensitivity (95% confidence interval) of chest X-ray screening by
the incidence method resulted in 79.7% (69.5–90.0%). Considering
these points, sensitivity of low-dose CT screening according to the
incidence method with 3–5 person-years of follow-up period
would be almost equal to that of chest X-ray screening. These
findings suggest that the efficacy of low-dose CT screening might
be limited to rapid-growing lung cancer with a short preclinical
detectable phase (o¼1 year). Since low-dose CT screening-
detected lung cancer is slow growing, further research with a
longer follow-up period is required.
A total of 40 lung cancer cases were detected by low-dose CT
screening, suggesting the possibility of overdiagnosis by low-dose
CT screening. In particular, low-dose CT screening detected 13
lung cancer cases in nonsmokers whereas expected incidence in
nonsmokers was only 1.7 persons. All of these cases were
peripheral adenocarcinoma. In contrast, expected lung cancer
incidence for the chest X-ray group was higher than the number of
screen-detected cases. This fact might suggest that there is little
possibility of overdiagnosis by chest X-ray screening.
Of the five interval cancer cases in the low-dose CT group, four
cases were squamous cell carcinoma or small cell carcinoma,
which are strongly associated with smoking (Sobue et al, 1991d;
Shimizu et al, 1994; Stellman et al, 2001). Three cases had
remarkable emphysaema. These interval cancer cases associated
with smoking indicate the limitation of low-dose CT screening for
Table 4 Sensitivity of screening by the incidence method; (a) low-dose CT group and (b) chest X-ray group
Person-years Expected incidence Screen-detected cases Interval cases Sensitivity (%) (95% CI)
(a) Low-dose CT group
Sex
Men 9173 21.8 29 3 86.2 (71.8–100)
Women 5512 2.5 11 2 20.0 (0–69.6)
Smoking status
Nonsmokers 4878 1.7 13 0 100
Ex-smokers 2388 4.2 6 1 76.2 (35.5–100)
Current smokers 7419 18.6 21 4 78.5 (59.8–97.2)
Total 14685 24.4 40 5 79.5 (63.5–95.5)
(b) Chest X-ray group
Sex
Men 17962 42.1 15 8 81.0 (69.1–92.8)
Women 41763 17.2 14 0 100
Smoking status
Nonsmokers 42976 17.4 13 0 100
Ex-smokers 8452 19.2 4 3 84.3 (68.1–100)
Current smokers 8297 22.8 12 5 78.1 (61.1–95.1)
Total 59725 59.3 29 8 86.5 (77.8–95.2)
CI¼confidence interval; CT¼computed tomography.
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sensitivity of low-dose CT screening identified using the detection
method is due to the detection of adenocarcinoma with a long
preclinical detectable phase.
This study has some limitations. First, many nodules were
detected by low-dose CT screening, but subsequent pathological
examinations were not performed. In this study, small pure
ground-glass opacity nodules (o10mm) were carefully observed,
and no invasive treatment was performed. In these cases, lung
cancer was highly suspected, but a lung cancer diagnosis was not
made and the cases were not registered in the OCR. Given the
presence of such cases, the sensitivity according to the detection
method might be underestimated. Second, to compare usual
screening with low-dose CT screening, the preclinical detectable
phase was assumed to be 1 year. We need to assess a longer
preclinical detectable phase, because most of the low-dose CT
screening-detected lung cancer cases were slow growing. Third, the
sample size was relatively small for proper evaluation, particularly
for stratified analyses.
In summary, the present findings suggest that lung cancer
screening using low-dose CT has a higher sensitivity and a lower
specificity than usual lung cancer screening by chest X-ray, when
using the detection method analysis. However, sensitivity esti-
mated by the incidence method was not as high as that estimated
by detection method. As all interval cancer cases were associated
with smoking, low-dose CT screening showed limited efficacy for
nonadenocarcinoma in smokers. Furthermore, these findings
demonstrate the potential for overdiagnosis in low-dose CT
screening-detected cases.
ACKNOWLEDGEMENTS
This study was supported by a grant-in-aid from the Ministry of
Health, Labor and Welfare of Japan for a Third term Comprehensive
Control Research for Cancer (Grant no. 19141901). We would like to
thank the staff of the Division of Epidemiology and the Osaka Cancer
Registry, Department of Cancer Control and Statistics, Osaka
Medical Center for Cancer and Cardiovascular Disease.
REFERENCES
Arai T, Kuroishi T, Saito Y, Kurita Y, Naruke T, Kaneko M, The Japanese
lung cancer research group (1994) Tumor doubling time and prognosis
in lung cancer: evaluation from chest films and clinical follow-up study.
Jpn J Clin Oncol 24: 199–204
Day NE (1985) Estimating the sensitivity of a screening test. J Epidemiol
Community Health 39: 364–366
Department of public health, Osaka Prefecture (2006) Smoking, Kenko
Osaka 21 Report, pp 26–64. Osaka Prefecture: Osaka
Diederich S, Thomas M, Semik M, Lenzen H, Roos N, Weber A, Heindel W,
Wormanns D (2004) Screening for early lung cancer with low-dose spiral
computed tomography: results of annual follow-up examinations in
asymptomatic smokers. Eur Radiol 14: 691–702
Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S (1993) Report of the
international workshop on screening for breast cancer. J Natl Cancer Inst
85: 1644–1656
Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR
(1986) Lung cancer screening: the Mayo Program. J Occup Med 28:
746–750
Henschke CI, Naidich DP, Yankelevitz DF, McGuinness G, McCauley DI,
Smith JP, Libby D, Pasmantier M, Koizumi J, Flieder D, Altorki N,
Miettinen OS (2001) Early lung cancer action project: initial findings on
repeat screenings. Cancer 92: 153–159
Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP,
Miettinen OS (2006) Survival of patients with Stage I lung cancer
detected on CT screening. New Eng J Med 355: 1763–1772
Jett JR (2005) Limitation of screening for lung cancer with low-dose spiral
computed tomography. Clin Cancer Res 11: 4988–4992
Libby DM, Wu N, Lee IJ, Faroogi A, Smith JP, Pasmantier MW,
MacCauley D, Yankelevitz DF, Henschke CI (2006) CT screening
for lung cancer: the value of short-term CT follow up. Chest 129:
1039–1042
Marcus PM, Bergstralh EJ, Fagerstrom RM, Williams DE, Fontana R,
Taylor WF, Prorok PC (2000a) Lung cancer mortality in Mayo Lung
Project: impact of extended follow-up. J Natl Cancer Inst 92: 1308–1316
Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS
(2006b) Extended lung cancer incidence follow-up in the Mayo Lung
Projects and overdiagnosis. J Nat Cancer Inst 98: 748–756
Nawa T, Nakagawa T, Kusano S, Kawasaki Y, Sugawara Y, Nakata H (2002)
Lung cancer screening using low-dose spiral CT: results of baseline and
1-year follow up studies. Chest 122: 15–20
Sagawa M, Nakayama T, Tsukada H, Nshii K, Baba T, Kurita Y, Saito Y,
Kaneko M, Sakuma T, Suzuki T, Fujimura S (2003a) The efficacy of lung
cancer screening conducted in 1990s: four case–control studies in Japan.
Lung Cancer 41: 29–36
Sagawa M, Saito Y, Takahashi S, Endo C, Usuda K, Kamma K, Sato M,
Ohkuda K, Sato H, Fujimura S (1994b) Sensitivity and specificity of lung
cancer screening with sputum cytology and chest X-ray film in high risk
group. Haigan 34: 1–5 (in Japanese)
Shimizu H, Nagata C, Tsuchiya E, Nakagawa K, Weng SY (1994) Risk of
lung cancer among cigarette smokers in relation to tumor location. Jpn J
Cancer Res 85: 1196–1199
Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R,
Kakimura R, Ohmatsu H, Nagai K, Nishiyama H, Matsui E, Eguchi K
(2002a) Screening for lung cancer with low-dose helical computed
tomography: anti-lung cancer project. J Clin Oncol 20: 911–920
Sobue T, Suzuki T, Fujimoto I, Matsuda M, Doi O, Mori T, Furuse K,
Fukuoka M, Yasumitsu T, Kuwahara O, Ichitani M, Taki T, Kuwabara M,
Nakahara K, Endo S, Sawamura K, Kurata M, Hattori S (1991d) Lung
cancer risk among ex-smokers. Jpn J Cancer Res 82: 273–279
Sobue T, Suzuki T, Matsuda M, Horai T, Kajita A, Kuriyama K, Fukuoka M,
Kusunoki Y, Kikui M, Ryu S, Fujimoto I (1991c) Sensitivity and
specificity of lung cancer screening in Osaka, Japan. Jpn J Cancer Res 82:
1069–1076
Sobue T, Yamamoto S, Hara M, Sasaduki S, Sasaki S, Tsugane S (2002b)
Cigarette smoking and subsequent risk of lung cancer by histologic type
in middle-aged Japanese men and women: the JPHC study. Int J Cancer
99: 245–251
Soda H, Tomita H, Kohno S, Oka M (1993) Limitation of annual
screening chest radiography for the diagnosis of lung cancer. Cancer
72: 2341–2346
Sone S, Li F, Yang ZG, Honda T, Maruyama Y, Takashima S, Hasegawa M,
Kawakami S, Kubo K, Haniuda M, Yamanda T (2001) Results of three-
year mass screening programme for lung cancer using mobile low-dose
spiral computed tomography scanner. Br J Cancer 84: 25–32
Stellman SD, Takezaki T, Wang L, Chen Y, Citron ML, Djordjevic MV,
Harlap S, Muscat JE, Neugut AI, Wynder EL, Ogawa H, Tajima K, Aoki K
(2001) Smoking and lung cancer risk in American and Japanese men: An
international case–control study. Cancer Epidemiol Biomarkers Prev 10:
1193–1199
Swensen SJ, Jett JR, Sloan JA, Midthun DE, Hartman TE, Slykes AM,
Aughenbaugh GL, Zink FE, Hillman SL, Noetzel GR, Marks RS,
Clayton AC, Pairolero PC (2002) Screening for lung cancer with
low-dose spiral computed tomography. Am J Respir Crit Care Med 165:
508–513
Tsukada H, Yokoyama A, Kurita Y, Misawa H (2002) Evaluation of
population based lung cancer screening in Niigata and analysis of
interval cases based on comparison lung cancer registry with screening
records. Nihon Kokyuki Gakkai Zasshi 38: 501–508 (in Japanese)
Yoshimi I, Ohshima A, Ajiki W, Tsukuma H, Sobue T (2003) A comparison
of trends in the incidence rate of lung cancer by histological type in the
Osaka Cancer Registry, Japan and in the Surveillance, Epidemiology and
Ends Results Program, USA. Jpn J Clin Oncol 33(2): 98–104
Zappa M, Castuglione G, Paci E, Grazzini G, Rubeca T, Turco P, Crocetti E,
Ciatto S (2001) Measuring interval cancers in population-based screen-
ing using different assays of fecal occult blood testing: the district of
Florence experience. Int J Cancer 92: 151–154
Sensitivity and specificity of CT screening
Y Toyoda et al
1607
British Journal of Cancer (2008) 98(10), 1602–1607 & 2008 Cancer Research UK
C
l
i
n
i
c
a
l
S
t
u
d
i
e
s